Learn More
2532 Background: Dendritic cells (DC) are a powerful tool for stimulating cell-mediated immunity through the effects of CD4+ and CD8+ T cells. This phase II study investigated AGS-003, an autologous(More)
80 Background: AGS-003 is an autologous dendritic cell (DC) immunotherapy prepared from matured monocyte-derived DC co-electroporated with the subject's own amplified tumor RNA and synthetic CD40L(More)
  • 1